» Articles » PMID: 22521198

Role of Intestinal Permeability and Inflammation in the Biological and Behavioral Control of Alcohol-dependent Subjects

Overview
Publisher Elsevier
Date 2012 Apr 24
PMID 22521198
Citations 153
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Aims: Mood and cognition alterations play a role in the motivation for alcohol-drinking. Lipopolysaccharides are known to stimulate inflammation that was shown to induce mood and cognitive changes in rodents and humans. Enhanced intestinal permeability and elevated blood LPS characterize alcohol-dependent mice. However, no data have been published in non-cirrhotic humans. Our first goal was to test whether intestinal permeability, blood LPS and cytokines are increased in non-cirrhotic alcohol-dependent subjects before withdrawal and if they recover after withdrawal. Our second goal was to test correlations between these biochemical and the behavioral variables to explore the possibility of a role for a gut-brain interaction in the development of alcohol-dependence.

Methods: Forty alcohol-dependent-subjects hospitalized for a 3-week detoxification program were tested at onset (T1) and end (T2) of withdrawal and compared for biological and behavioral markers with 16 healthy subjects. Participants were assessed for gut permeability, systemic inflammation (LPS, TNFα, IL-6, IL-10, hsCRP) and for depression, anxiety, alcohol-craving and selective attention.

Results: Intestinal permeability and LPS were largely increased in alcohol-dependent subjects at T1 but recovered completely at T2. A low-grade inflammation was observed at T1 that partially decreased during withdrawal. At T1, pro-inflammatory cytokines were positively correlated with craving. At T2 however, the anti-inflammatory cytokine IL-10 was negatively correlated with depression, anxiety and craving.

Conclusion: Leaky gut and inflammation were observed in non-cirrhotic alcohol-dependent subjects and inflammation was correlated to depression and alcohol-craving. This suggests that the gut-brain axis may play a role in the pathogenesis of alcohol-dependence.

Citing Articles

Alcohol Use Disorder and the Gut-Brain Axis: A Narrative Review of the Role of Gut Microbiota and Implications for Treatment.

Shukla S, Hsu C Microorganisms. 2025; 13(1).

PMID: 39858835 PMC: 11767426. DOI: 10.3390/microorganisms13010067.


Developing a translational research framework for MDD: combining biomolecular mechanisms with a spiraling risk factor model.

van Baalen M, van der Velden L, van der Gronde T, Pieters T Front Psychiatry. 2025; 15():1463929.

PMID: 39839132 PMC: 11747824. DOI: 10.3389/fpsyt.2024.1463929.


Mapping the relationship between alcohol use disorder and gut microbiota: a 20-year bibliometric study.

Xiang A, Chang Y, Shi L, Zhou X Front Microbiol. 2024; 15:1457969.

PMID: 39624719 PMC: 11609174. DOI: 10.3389/fmicb.2024.1457969.


Intragastric administration of short chain fatty acids greatly reduces voluntary ethanol intake in rats.

Quintanilla M, Santapau D, Diaz E, Valenzuela Martinez I, Medina N, Landskron G Sci Rep. 2024; 14(1):29260.

PMID: 39587197 PMC: 11589138. DOI: 10.1038/s41598-024-80228-1.


Linking alcohol use to Alzheimer's disease: Interactions with aging and APOE along immune pathways.

Monnig M, Shah K Med Res Arch. 2024; 12(8).

PMID: 39544182 PMC: 11563488. DOI: 10.18103/mra.v12i8.5228.